All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
IBB real return snapshot: after CPI-U inflation, IBB returned +31.79% over the past year and +16.74% YTD, with dividends reinvested. Since Feb. 9, 2001, IBB is up +230.29% in real purchasing-power return, or +4.76%/yr, and is currently −6.47% below its real total-return high on Feb. 8, 2021.
Data ending Mon Oct. 12, 2026
| Fri 2001-02-09💬 to Mon 2026-10-12 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| IBB × |
+230.29%
+4.76%/yr |
+8.00%/yr
R2=0.802 |
||||
| iShares Biotechnology ETF NASDAQ Exchange-Traded Fund | ||||||
| Fri 2001-02-09💬 to Mon 2026-10-12 |
Start
Value |
End
Value |
|---|---|---|
| IBB × |
$10,000.00
2001-02-09 |
$33,029.21
2026-10-12 |
| YTD | YoY | |
|---|---|---|
| IBB × | +16.74% | +31.79% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| IBB × |
−6.47%
on 2026-10-12 from 2021-02-08 peak |
−63.31%
on 2002-07-10 from 2001-06-05 peak |
| Period ending Mon 2026-10-12 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| IBB × | +31.79% |
+32.12% +14.94%/yr |
+55.42% +15.83%/yr |
+9.43% +1.82%/yr |
+67.15% +5.27%/yr |
| Year | IBB |
|---|---|
| 2026 (YTD) | +16.74% |
| 2025 | +24.65% |
| 2024 | −5.14% |
| 2023 | +0.40% |
| 2022 | −18.93% |
| 2021 | −5.69% |
| 2020 | +24.32% |
| 2019 | +22.62% |
| 2018 | −11.22% |
| 2017 | +18.57% |
| 2016 | −23.01% |
| 2015 | +10.75% |
| 2014 | +32.83% |
| 2013 | +63.09% |
| 2012 | +29.88% |
| 2011 | +8.49% |
| 2010 | +13.15% |
| 2009 | +12.12% |
| 2008 | −12.36% |
| 2007 | +0.41% |
| 2006 | −1.80% |
| 2005 | −0.95% |
| 2004 | +1.49% |
| 2003 | +43.11% |
| 2002 | −47.06% |
| 2001 | −10.60% |
